Table 7.
Starting Dose (mg) | Usual/Maximal Dose (mg) | Comments/Side Effects | |
---|---|---|---|
Antipsychotics | |||
Aripiprazole | 2 | 7–12 QD | Weight neutral, metabolic abnormalities |
Olanzapine | 2.5 | 5–10 QD to BID | Weight gain, sedation, metabolic abnormalities |
Quetiapine | 12.5 | 50–200 QD to BID | Orthostasis, sedation, metabolic abnormalities |
Risperidone | 0.25 | 0.5–1.5 QD to BID | Weight gain, sedation, hyperprolactinemia, metabolic abnormalities. Risk of EPS at higher doses. |
Ziprasidone | 20 | 60–80 QD to BID | Less risk of metabolic abnormalities, greater risk of QT prolongation |
Other medications | |||
Trazodone | 25 QD to BID | 50–250 daily | Can use q4h or prior to usual sundowning, or at HS, being careful about maximal dosing. Sedation, orthostasis, rare cardiac conduction abnormalities. |
SSRIs | See Table 5 for dosing and considerations | ||
Lamotrigine | 25 daily | 50–400 daily | Slow titration; observe for Stevens-Johnson syndrome |
Gabapentin | 100 QD to BID | Up to 1800 in divided doses | Renally excreted |
Memantine or cholinesterase inhibitors | Usual dosing |
Abbreviations: BID, 2 times a day; EPS, extrapyramidal symptoms; HS, at bedtime; q4h, every 4 hours; QD, every day; QT, QT interval; SSRI, selective serotonin reuptake inhibitor.